Literature DB >> 6367949

On the histogenesis of Ewing's sarcoma. An ultrastructural, immunohistochemical, and cytochemical study.

J J Navas-Palacios, R Aparicio-Duque, M D Valdés.   

Abstract

Forty-two cases of Ewing's sarcoma (ES) have been studied with light microscopy during the 9-year period 1974 to 1982. Thirty-three patients had ES of bone, and in 9 patients the tumor was located in the extraskeletal soft tissues. Cases which fulfilled all the morphologic criteria were accepted as typical ES (31 cases), and those with some architectural or cytologic peculiarities were considered atypical forms of ES (11 cases). An immunohistochemical study (PAP method) to evaluate the presence in the tumor cells of the following markers: myoglobin, F-VIII-related antigen, lysozyme, alpha-1-antitrypsin, alpha-1-antichymotrypsin, and immunoglobulins (IgG, IgA, IgM, kappa and lambda light chains), was performed with negative results in all cases (paraffin blocks were available in 38 cases). The cytochemical study on fresh tissue imprints from five patients (PAS, Sudan Black, alpha-naphthyl acetate esterase, acid phosphatase, beta glucuronidase, myeloperoxidases, naphthol-AS-D chloroacetate esterase and alkaline phosphatase) gave no pattern of histogenetic significance, PAS being the best morphologic marker in tissue sections and touch preparations. A detailed ultrastructural study was performed on 34 cases; the main findings may be summarized as follows: medium sized cells, polygonal shape, oval nuclei, smooth nuclear envelope, abundant euchromatin, well-developed nucleolonema, scant membranous organelles, abundant hyaloplasmic glycogen, occasional lipid vacuoles, straight cell membranes, and primitive intercellular junctions. No differences were found between bone and extraskeletal ES; moreover, typical and atypical forms showed moderate quantitative differences with no qualitative change. The histogenesis is discussed; no functional or morphologic markers have been found to suggest the cell of origin; however, some cell lines may be excluded. It is the impression of the authors that they are dealing with a primitive noncommitted mesenchymal cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367949     DOI: 10.1002/1097-0142(19840501)53:9<1882::aid-cncr2820530915>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Small round cell tumours of bone.

Authors:  R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Experimental evidence for a neural origin of Ewing's sarcoma of bone.

Authors:  A O Cavazzana; J S Miser; J Jefferson; T J Triche
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

Review 3.  Surgical pathology of bone sarcomas.

Authors:  A G Huvos
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

4.  Ewing's sarcoma of humerus with epithelial differentiation.

Authors:  G C Steiner; S Matano; D Present
Journal:  Skeletal Radiol       Date:  1995-07       Impact factor: 2.199

5.  Extraskeletal Ewing's sarcoma with fatal cardiac metastasis.

Authors:  R M Flinn; A Foyle; T J Montague
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

6.  Is There a Predisposition Gene for Ewing's Sarcoma?

Authors:  R L Randall; S L Lessnick; K B Jones; L G Gouw; J E Cummings; L Cannon-Albright; J D Schiffman
Journal:  J Oncol       Date:  2010-03-15       Impact factor: 4.375

7.  Induction of glycogenolysis in cultured Ewing's sarcoma cells by dopamine and beta-adrenergic agonists.

Authors:  F van Valen; E Keck
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

8.  Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells.

Authors:  F van Valen; W Winkelmann; H Jürgens
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma.

Authors:  Stefan K Zöllner; Saravana P Selvanathan; Garrett T Graham; Ryan M T Commins; Sung Hyeok Hong; Eric Moseley; Sydney Parks; Jessica N Haladyna; Hayriye V Erkizan; Uta Dirksen; Michael D Hogarty; Aykut Üren; Jeffrey A Toretsky
Journal:  Sci Signal       Date:  2017-10-03       Impact factor: 8.192

10.  Ewing's sarcoma. A retrospective study of histological and immunohistochemical factors and their relation to prognosis.

Authors:  S Daugaard; C Kamby; L M Sunde; O Myhre-Jensen; T Schiødt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.